PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
17317846-10	2007	The results provide clinical implications that therapeutic targeting at the BRAF/MEK/MAP kinase pathway may be a good approach in restoring thyroid gene expression for effective radioiodine therapy for BRAF mutation-harboring PTC.	Iodine-131	178-189	B-Raf proto-oncogene, serine/threonine kinase	Homo sapiens	76-80	
17317846-10	2007	The results provide clinical implications that therapeutic targeting at the BRAF/MEK/MAP kinase pathway may be a good approach in restoring thyroid gene expression for effective radioiodine therapy for BRAF mutation-harboring PTC.	Iodine-131	178-189	B-Raf proto-oncogene, serine/threonine kinase	Homo sapiens	202-206